Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma

C Farah, L Mignion, BF Jordan - International journal of molecular …, 2024 - mdpi.com
There is currently no consensus to determine which advanced melanoma patients will
benefit from targeted therapy, immunotherapy, or a combination of both, highlighting the …

Melanoma metabolism: cell survival and resistance to therapy

R Luis, C Brito, M Pojo - Tumor Microenvironment: The Main Driver of …, 2020 - Springer
Cutaneous melanoma is one of the most aggressive types of cancer, presenting the highest
potential to form metastases, both locally and distally, which are associated with high death …

Metabolic interplay between the immune system and melanoma cells: therapeutic implications

A Indini, F Grossi, M Mandalà, D Taverna, V Audrito - Biomedicines, 2021 - mdpi.com
Malignant melanoma represents the most fatal skin cancer due to its aggressive biological
behavior and high metastatic potential. Treatment strategies for advanced disease have …

Metabolic Imaging Biomarkers of Response to Signaling Inhibition Therapy in Melanoma

PK Gupta, S Orlovskiy, F Arias-Mendoza, DS Nelson… - Cancers, 2024 - mdpi.com
Simple Summary In vivo, 1H and 31P magnetic resonance spectroscopy were used to study
human melanoma models to monitor the metabolic effects of dabrafenib therapy, an inhibitor …

[HTML][HTML] 1H and 31P Magnetic Resonance Spectroscopic Metabolomic Imaging: Assessing Mitogen-Activated Protein Kinase Inhibition in Melanoma

PK Gupta, S Orlovskiy, F Arias-Mendoza, DS Nelson… - Cells, 2024 - mdpi.com
The MAPK signaling pathway with BRAF mutations has been shown to drive the
pathogenesis of 40–60% of melanomas. Inhibitors of this pathway's BRAF and MEK …

Metabolic traits in cutaneous melanoma

M Neagu - Frontiers in oncology, 2020 - frontiersin.org
Tumor microenvironment is a network of complex cellular and molecular systems where
cells will gain specific phenotypes and specific functions that would drive tumorigenesis. In …

Molecular probes for malignant melanoma imaging

G Ren, Y Pan, Z Cheng - Current pharmaceutical …, 2010 - ingentaconnect.com
Malignant melanoma represents a serious public health problem and is a deadly disease
when it is diagnosed at late stage. Though 18F-fluorodeoxyglucose (18F-FDG) positron …

Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: predict before protect

X Zhang, Z Tai, F Miao, H Huang, Q Zhu, L Bao… - Frontiers in …, 2022 - frontiersin.org
Malignant melanoma is widely acknowledged as the most lethal skin malignancy. The
metabolic reprogramming in melanoma leads to alterations in glycolysis and oxidative …

Future perspectives in melanoma research: meeting report from the" Melanoma Bridge", Napoli, December 5th-8th 2013

Abstract The fourth" Melanoma Bridge Meeting" took place in Naples, December 5 to 8 th,
2013. The four topics discussed at this meeting were: Diagnosis and New Procedures …

[HTML][HTML] Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine

A Tarhini, RR Kudchadkar - Cancer treatment reviews, 2018 - Elsevier
The treatment armamentarium for patients with metastatic melanoma has increased
substantially over the past decade with the regulatory approval of targeted BRAF+ MEK …